Papers
10
Total Citations
254
H-Index
7
About
Chuxiong Ding is a medical physicist and radiation oncology researcher whose work has significantly advanced the clinical application of stereotactic body radiation therapy (SBRT) and radiosurgery. His research spans several critical domains, including robotic and conventional linac-based radiation delivery systems, partial breast irradiation, lung cancer treatment, and cerebrovascular malformations. Ding's comparative dosimetric analyses between robotic CyberKnife and conventional linac-based SBRT platforms have provided invaluable clinical guidance, with his 2010 lung cancer study alone accumulating 52 citations. His foundational work on optimizing normalized prescription isodose selection has helped standardize treatment planning across delivery modalities. Perhaps most notably, Ding has been a driving force behind a pioneering phase 1 dose-escalation trial exploring 5-fraction stereotactic partial breast irradiation for early-stage breast cancer, a body of work generating over 80 combined citations and spanning cosmetic outcome evaluations critical to patient quality of life. His 2018 overview of CyberKnife treatment planning systems has become a widely referenced resource with 59 citations, underscoring his authority in translating complex radiation physics into actionable clinical frameworks. Ding's contributions represent a sustained commitment to precision, innovation, and improved patient outcomes in radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10